SYSTEMIC SCLERODERMA
Clinical trials for SYSTEMIC SCLERODERMA explained in plain language.
Never miss a new study
Get alerted when new SYSTEMIC SCLERODERMA trials appear
Sign up with your email to follow new studies for SYSTEMIC SCLERODERMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug firsekibart tested for scleroderma skin hardening
Disease control Not yet recruitingThis study tests a new drug called firsekibart in 30 adults with a severe form of systemic sclerosis (scleroderma) that affects the skin. The goal is to see if the drug can reduce skin thickening and improve overall disease symptoms. Participants will receive the drug and be comp…
Matched conditions: SYSTEMIC SCLERODERMA
Phase: NA • Sponsor: Tongji Hospital • Aim: Disease control
Last updated May 12, 2026 13:43 UTC
-
Stem cell shots aim to unlock jaws of scleroderma patients
Symptom relief Not yet recruitingThis study tests whether injections of donated stem cells around the mouth can reduce scarring and improve mouth function in people with systemic scleroderma. About 50 adults with limited mouth opening will receive either stem cells or a placebo. The main goal is to see if mouth-…
Matched conditions: SYSTEMIC SCLERODERMA
Phase: PHASE2 • Sponsor: University Hospital, Toulouse • Aim: Symptom relief
Last updated May 13, 2026 16:02 UTC
-
Scientists to investigate troublemaker cells in autoimmune diseases
Knowledge-focused Not yet recruitingThis study aims to better understand certain immune cells (B cells) that mistakenly attack the body in autoimmune diseases like lupus and scleroderma. Researchers will analyze blood samples from 200 adults with these conditions or with immune deficiencies. The goal is to identify…
Matched conditions: SYSTEMIC SCLERODERMA
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated May 17, 2026 02:41 UTC